Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
JAMA Network Open|August 4, 2022
Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung CancerMatthew D Pichert, Maureen E Canavan, Richard C Maduka, et al.
JMIR Cancer|November 2, 2023
Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional StudyVictoria A Marks, Walter R Hsiang, James Nie, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 27, 2006
Extended use of extracorporeal membrane oxygenation after lung transplantationDavid P Mason, Daniel J Boffa, Sudish C Murthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as ThoracotomyDaniel J Boffa, Andrzej S Kosinski, Anthony P Furnary, et al.
Annals of Surgery|April 27, 2018
Quality Versus Quantity: The Potential Impact of Public Reporting of Hospital Safety for Complex Cancer SurgeryAlexander S Chiu, Brian N Arnold, Jessica R Hoag, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2017
Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse SurvivalDaniel J Boffa, Ryon P Graf, Michelle C Salazar, et al.
Communications Biology|March 29, 2025
Cigarette smoke induces angiogenic activation in the cancer field through dysregulation of an endothelial microRNAAsawari Korde, Anuradha Ramaswamy, Seth Anderson, et al.
Journal of the American College of Surgeons|January 27, 2026
Surgical Trainee Familiarity and Knowledge of the Commission on Cancer (CoC) Operative Standards: A National Survey StudyAlison S Baskin, Elizabeth C Funk, Jack W Sample, et al.
Annals of Surgery|October 21, 2020
Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 PandemicDaniel J Boffa, Benjamin L Judson, Kevin G Billingsley, et al.
Journal for Immunotherapy of Cancer|July 26, 2019
Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaNicholas D Klemen, Melinda Wang, Paul L Feingold, et al.
Pageof 18